2017
DOI: 10.1016/j.intimp.2017.05.016
|View full text |Cite
|
Sign up to set email alerts
|

LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(27 citation statements)
references
References 34 publications
2
24
0
Order By: Relevance
“…Previous reports have established that MRGPRX2-induced mast cell activation results in downstream signaling events that activate the MAP kinase ERK1/2 (46). This signaling pathway ultimately regulate mast cell degranulation and cytokine production (47,48).…”
Section: Osthole Inhibits Chemokine/cytokine Production and Mitogen-amentioning
confidence: 97%
“…Previous reports have established that MRGPRX2-induced mast cell activation results in downstream signaling events that activate the MAP kinase ERK1/2 (46). This signaling pathway ultimately regulate mast cell degranulation and cytokine production (47,48).…”
Section: Osthole Inhibits Chemokine/cytokine Production and Mitogen-amentioning
confidence: 97%
“…MCs can be activated by peptides derived from endogenous and exogenous sources[3739]. LL-37, which is found within leukocytes and several tissues and bodily fluids in humans[40], binds human MCs through the MRGPRX2 receptor triggering degranulation and de novo secretion of cytokines, such as IL-8[37]. The adjuvant activity of LL-37 was demonstrated using an oral vaccine against Dengue virus[41].…”
Section: Vaccine Adjuvant Activity Of Mast Cell Activators (Mca)mentioning
confidence: 99%
“…MRGPRX2 displays a promiscuous ligand-binding domain that is potently activated by a variety of different cationic peptides and chemical effectors (10)(11)(12)(13). The cathelicidin peptide LL-37 (13,14), neuropeptide cortistatin-14 (CST-14) (10,15), and mast cell-degranulating molecule compound 48/80 (3,16) especially, produce robust degranulation responses through MRGPRX2. LL-37 expression is upregulated in patients with chronic inflammatory skin conditions such as rosacea (17), suggesting that mast cell activation via MRGPRX2 may be responsible for the symptoms associated with this disease.…”
Section: Introductionmentioning
confidence: 99%